Coronary Anomalies in Congenital Heart Disease

NCT ID: NCT01278771

Last Updated: 2011-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective study. The investigators shall review the angiography data of 1200 consecutive cardiac catheterizations of children and babies with CHD (Congenital Heart Disease) since 1998 till now.

Coronary artery origin and course will be evaluated in relation to the morphologic cardiac anomalies.

Coronary artery anomalies will be described and statistical analysis will be performed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cradiac catheterization with angiography with congenital heart disease.

Exclusion Criteria

* no congenital heart disease.
Maximum Eligible Age

86 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rambam Health Care Campus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rambam Medical Center, Meyer Children's Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Avraham Lorber, Prof

Role: PRINCIPAL_INVESTIGATOR

Rambam Medical Health Care Campus

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0496CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diabetic Cardiomyopathy
NCT04593173 UNKNOWN
The SMARTER Cardiomyopathy Study
NCT05750147 RECRUITING